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Abstract
Background: Core outcome sets (COS) prioritise outcomes based on their importance to key stakeholders, reduce
reporting bias and increase comparability across studies. The first phase of a COS study is to form a ‘long-list’ of
outcomes. Key stakeholders then decide on their importance. COS reporting is described as suboptimal and this
first phase is often under-reported. Our objective was to develop a ‘long-list’ of outcome items for non-pharmacological
interventions for people with dementia living at home.
Methods: Three iterative phases were conducted. First, people living with dementia, care partners, health and social care
professionals, policymakers and researchers (n = 55) took part in interviews or focus groups and were asked
which outcomes were important. Second, existing dementia trials were identified from the ALOIS database. 248
of 1009 pharmacological studies met the inclusion criteria. Primary and secondary outcomes were extracted from a 50%
random sample (n = 124) along with eight key reviews/qualitative papers and 38 policy documents. Third, extracted
outcome items were translated onto an existing qualitative framework and mapped into domains. The research team
removed areas of duplication and refined the ‘long-list’ in eight workshops.
Results: One hundred seventy outcome items were extracted from the qualitative data and literature. The 170
outcome items were consolidated to 54 in four domains (Self-Managing Dementia Symptoms, Quality of Life,
Friendly Neighbourhood & Home, Independence).
Conclusions: This paper presents a transparent blueprint for ‘long-list’ development. Though a useful resource
in their own right, the 54 outcome items will be distilled further in a modified Delphi survey and consensus
meeting to identify core outcomes.
Keywords: Core outcome set, Delphi survey long-list, Dementia, Neighbourhood, Non-pharmacological, Literature review,
Qualitative research
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Background
Recent estimates suggests that there are 850,000 people
in the UK and 46.8 million globally who live with dementia
[1]. Many people with dementia live alone and are particu-
larly reliant on support in everyday living from family
members, community services and home care agencies [2].
A range of different interventions are available for people
living with dementia in their neighbourhoods and commu-
nities, including pharmacological and non-pharmacological
(i.e. non drug based) interventions, to ensure support and
care are offered throughout the person’s life. Support inter-
ventions at home, including environmental adaptations and
assistive technologies, have been designed to enable people
living with dementia to maintain their independence and
live well with their diagnosis [3, 4]; however, evidence
on the effectiveness of those interventions requires develop-
ment [5, 6]. There is a growing demand to evaluate and im-
prove the effectiveness of non-pharmacological community-
based interventions and optimise outcomes for people living
with dementia at home in their neighbourhoods and com-
munities [7–9].
Robustly designed evaluations are necessary to deter-
mine if an intervention is effective. When looking at the
effectiveness of an intervention(s), randomised experi-
ments or trials are considered to be the ‘gold standard’
of evaluation [10]. One of the central pillars of evalu-
ation and trial methodology is to compare outcomes of
those receiving the experimental intervention and those
who do not to measure and contrast beneficial or harmful
effects. Ruling out almost all rival explanations for the out-
comes observed is possible in a randomised experimental
design. The selection of appropriate outcomes is therefore
a crucial part of designing trials and evaluations [11, 12].
The term ‘outcome’ commonly refers to the impact of
activity or support and services, and is defined in the
Good Indicator Guide as “a measurable change in health
status, sometimes attributable to a risk factor or an inter-
vention” [13]. In practice, every intervention and/or ser-
vice is designed to achieve an outcome. These outcomes
can be specific or diverse focusing on, for example, quality
of care, service supports, improvement in physical, mental
or emotional wellbeing and so on [14].
However, existing outcome measures in relation to trials
of non-pharmacological interventions for people living
with dementia have two major limitations. The first limita-
tion relates to which outcome measures are adopted and
how choices are made to include outcome measures.
While the choice of applied outcome(s) may be relevant
to the intervention, what is important to those with lived
experience of health conditions often contrasts with pro-
fessional perspectives [15]. Indeed, outcomes that are sali-
ent to the intervention may not always be consistent with
what people living with dementia value. This is perhaps
symptomatic of a wider societal issue where people living
with dementia are all too often positioned as a ‘seldom
heard group’, encounter stigma on a regular basis[16], and
are often not consulted about what outcomes are import-
ant to measure and, by implication, what interventions
therefore might be desirable [16, 17]. Whilst the perspec-
tives of people living with dementia and carers on desir-
able outcomes of community care captured by Bamford
and Bruce constitutes important research [18], it is nearly
two decades old. In recent years recommendations relat-
ing to outcome measures for use in dementia trials has
mainly come from professional groups [19]. People living
with dementia are rarely, if at all, consulted [20]. There is
wider evidence from research in other fields that patients
or the public have identified outcomes that were not pre-
viously identified by trialists [21]. The merit of many trials
on non-pharmacological community-based interventions
for people living with dementia, and possibly the effective-
ness of interventions, may be questionable if research
focuses on outcomes that are not identified as being of
importance to people living with dementia and other key
stakeholders.
The second limitation is that given a lack of consensus
and transparency about which outcomes are salient and
important, many completed and on-going studies that
evaluate interventions for people living with dementia
have a high degree of variation in relation to what out-
comes are used and even how they are measured [8, 22].
This hinders the potential to compare for effectiveness
across studies and makes both the meta-analysis and in-
terpretation of results difficult.
These limitations provide the rationale for the creation
of a core outcome set (COS) [11, 12]. The Core Out-
come Measures in Effectiveness Trials (COMET) Initia-
tive website (www.comet-initiative.org/) describes a COS
as representing:
“…the minimum that should be measured and
reported in all clinical trials... The existence or use of
a core outcome set does not imply that outcomes in a
particular trial should be restricted to those in the
relevant core outcome set. Rather, there is an
expectation that the core outcomes will be collected
and reported, making it easier for the results of trials
to be compared, contrasted and combined as
appropriate; while researchers continue to explore
other outcomes as well.”
In recent years, core outcome set developers have used
a number of similar phases when creating a COS [11].
The first phase focuses on developing a comprehensive
‘long-list’ of outcomes that are currently used in existing
trials and literature, along with outcomes that are identi-
fied as important through qualitative research with key
stakeholder groups. Subsequent phases involve Delphi
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surveys to rate the importance of the identified ‘long-list’
of outcomes, a consensus meeting in order to arrive at
agreement about what outcomes should be regarded as
core, and a systematic review(s) and/or other methods
to identify and assess existing measurement instruments
that correspond to core outcomes [11].
This study methodology, including how we have uti-
lised the lived experience of people living with dementia
as co-researchers [23] to modify and design an accessible
Delphi method is outlined in greater detail elsewhere
[19, 24]. The clarity and transparency of COS reporting
is described in a recent review as suboptimal [25] and
the important initial phase of developing the ‘long-list’
often goes under reported. In this paper we report on
the development of the ‘long-list’ of outcomes for use in
non-pharmacological community based interventions for
people with dementia who live at home.
Methods
There were three parts within the first phase of this
mixed method study. First (Phase 1a), interviews and
focus groups were undertaken with key stakeholder
groups that asked which outcomes they thought were
important from the perspectives of a person living with
dementia. As outlined in the study protocol [19], these
groups were:
1. People living with dementia - a person either
formally or self-diagnosed with dementia and who
lives at home.
2. Care partners [19] - a person with current or past
experiences of providing care for a person living
with dementia.
3. Health and social care professionals – a person
currently or recently employed by a public or private
organisation that provides care or support in a health
or social setting for people living with dementia.
4. Researchers – a person with current or recent
experiences of undertaking dementia related research
(i.e. as denoted by being a lead or co-author on
dementia related peer-reviewed publications, or
involvement in current dementia-related research).
5. Policymakers - a person in a senior role with
influence to shape national, regional or local
dementia policy, or commission dementia service
provision. This includes those who plan services.
Details of inclusion/exclusion criteria and recruitment
processes can be found in the study protocol [19]. The
second part of phase one (Phase 1b) relates to identify-
ing outcomes as described in existing research literature.
The third part of phase 1 (Phase 1c) relates to removing
unsuitable items and consolidating outcomes extracted
during 1a and 1b to a quantity that is manageable for
the Delphi survey. The methods of each of these three
parts are outlined below. For the purposes of this paper
we are describing items identified as outcome items, but
note that further work may be required to translate
these outcome items into measurable outcomes in later
stages of this study.
Phase 1a: qualitative research with key stakeholders
Fifty-five people participated in 35 interviews and four
focus groups. Participants included people living with
dementia, care partners, health and social care profes-
sionals and policymakers. Participants were based across
the UK, although mostly in the North West of England.
Table 1 presents the participants and method.
All interviews and focus groups were audio recorded,
transcribed and data were managed in NVIVO version
11. The a-priori aim of the interviews and focus groups
was to develop a list of outcomes identified as important
by stakeholders. With this aim in mind, an adapted ver-
sion of Braun and Clarke’s [26] six stages of thematic
analysis was applied to develop a thematic framework.
We outline here Braun and Clarke’s six stages and detail
how we adapted them:
 Phase 1: Familiarisation: repeated reading of the data
and reading the data in an active way.
 Phase 2: Generating initial codes: identifying
emerging codes that relate to outcome items and
areas that were considered to be important to
people living with dementia.
 Phase 3: Searching for themes, looking through
codes to see how they fit with each other.
 Phase 4: Themes were reviewed, including merging
and collating them into groups where necessary,
including use of a-priori themes adapted from Bamford
and Bruce’s [18] framework to refine the themes
further.
 Phase 5: Themes and outcome items were defined
and names finalised.
 Phase 6: Given that we were developing a list of
outcome items for a Delphi survey we did not
produce an emerging narrative. Instead we developed
Table 1 Participants in phase 1a qualitative research
Participant groups Interviews Focus groups Total
Participants
People living with dementia 14 1 (n = 3) 17
Care partners 8 2 (n = 5,5) 18
Health & social care
professionals
8 1 (n = 7) 15
Policy makers 4 0 4
Researchers 1 0 1
35 20 55
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a framework of outcome items deemed important to
people living with dementia. This is the key adaption
to Braun and Clarke’s [26] thematic analysis.
Phase 1b: extraction of outcomes from existing trials
The Cochrane Dementia and Cognitive Improvement
Group, at The Medical Sciences Division at Oxford
University, manages the ALOIS database - a compre-
hensive and open access database of dementia studies
(http://www.medicine.ox.ac.uk/alois/). ALOIS is updated
by monthly searches of Medline, Embase, PsycINFO, Web
of Science Core Collection, ClinicalTrials.gov, World
Health Organisation International Clinical Trial Registry
Platform meta-registry, Cochrane Controlled Register of
Controlled Trials (CENTRAL) and LILACs (via Bireme) in-
put into ALOIS. The database contains records of rando-
mised controlled trials, controlled clinical trials and other
‘open-label’ studies. The advanced search function allows
users to search by study aim, study design, intervention
type (Any, Non-pharmacological, Pharmacological,
Unclear or Both) or whether records are Cochrane
studies. In January 2016 the ALOIS database was used to
extract outcomes adopted in existing non-pharmacological
interventions, applying the following inclusion criteria:
Types of participants
 People with dementia living at home in their
neighbourhood/community
Types of interventions
Any UK based or international non-pharmacological
intervention focusing on people living with dementia at
home, which aimed to support people living with de-
mentia in their neighbourhoods and communities. This
included for example assistive technology (e.g. trials in-
vestigating the efficacy/outcomes associated with cognitive
aids, environmental sensors, video and audio technologies,
and advanced integrated sensor systems used in the home
for people with dementia); psycho-social (e.g. psycho-
dynamic approaches, reminiscence and life review therapy,
support groups, reality orientation, memory training, and
cognitive/behavioural approaches); psychological; social;
nutritional (excluding medical supplements); educational;
literature-based (e.g. book clubs); carer focused interventions
if outcomes for people living with dementia were reported.
The following exclusion criteria were applied:
Types of participants
 People without a diagnosis of dementia (e.g. healthy
older people, people with mild cognitive impairment)
 People living with dementia in any form of
residential care
Type of intervention
 Pharmacological
 Electrophysiological
 Other medical device driven interventions
A total of 1009 studies registered as non-pharmacological
were extracted from the ALOIS database, of which 248
studies met the inclusion criteria. The purpose of the litera-
ture review was to determine the outcomes used in existing
research to complement the outcomes identified from in-
terviews and focus groups with people with dementia, their
care partners, health and social care professionals, and
policymakers, commissioners and research leaders. As such,
we extracted outcomes from a 50% random sample of the
identified studies (n=124). During the outcomes extraction
process we observed that no new outcome was added and
that we had reached a saturation point at 50%. Outcomes
and their respective measures or tools used were extracted
verbatim into a MS Excel spreadsheet. In addition, and in
order to be as comprehensive as possible, key reviews and
qualitative studies (n = 8) and policy documents (n = 38)
were also identified based on the knowledge of the research
team and the study advisory group. All outcomes from
these 170 sources were extracted and added to the afore-
mentioned framework, if not already included, to constitute
a ‘long-list’ of outcome items.
Phase 1c: developing the ‘long-list’: researcher/clinician
group based workshops
In an approach similar to that of other COS developers
[27], eight sequential workshops with members of the
research team were convened with a view to remove
duplication, further consolidate areas of commonality
and map outcome items into domains. These workshops
were adapted from existing interactive focus group ap-
proaches [28, 29]. Each workshop typically involved 4–6
people. All meetings where attended by AH, HM, FA
and SR. IL, JK and DC independently attended one
workshop each. CS and PW provided input over email.
Each workshop was between 2 and 4 h in duration. Advis-
ory group members were also sent iterations of outcome
item frameworks and provided input at different stages.
Participants were sent copies of the existing framework
of outcome items in preparation for each workshop. Send-
ing these materials in advance allowed participants to be-
come familiar with the current configuration of outcome
items and to form points of discussion about how and
why outcome items should be moved or removed. In the
workshop, each outcome item was listed in a spreadsheet
and printed on individual pieces of paper. These were
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subsequently laid out on large tables and participants en-
gaged in discussion about each. Individual outcome items
were reviewed and re/positioned under different domains
while participants exchanged views around the rationale
for mapping outcome items into domains, merging or re-
moving them. Decisions were recorded and logged follow-
ing each workshop allowing the research team to track the
journey of outcome items that had been moved or re-
moved and also to revisit the rationale for decisions taken.
The team met until there was consensus that this delib-
erative analysis had reached saturation.
Results
A total of 170 items were extracted from the qualitative
data and existing literature. The origin of these 170
items are as follows:
 79 were extracted from qualitative data collection
with key stakeholders
 77 were extracted from the reviewed non-
pharmacological studies registered on the ALOIS
database
 13 were extracted from policy documents
 One additional area was extracted from key reviews
and qualitative papers.
However, as outlined in the previous section where
possible outcomes extracted from existing studies were
added to the existing qualitative framework. On this
basis, during the initial extraction, forty-nine of the out-
comes extracted from the literature were able to be
mapped on to the qualitative framework, establishing
121 outcome items – of which 28 originated from the
literature. The outcome items were placed in initial
groupings by the research team upon extraction. These
121 outcome items, and the actions taken over the eight
workshops (i.e. whether they were merged or removed)
for each item, is presented in Table 2.
The eight workshops previously described reduced the
121 outcome items to 53 and categorised them into do-
mains. Some outcome items were selected as overarching
domains, others were merged or removed. Outcome items
were merged if they were judged sufficiently similar to
other items, or even present across a cluster or number of
outcome items. A common reason for removing an out-
come item was if it fell outside of the remit of the COS.
This included that the item did not focus on the person
living with dementia, was a cost related outcome or was
an intermediate/service/process outcome. One outcome
item was removed because it referred to wider structural
factors around the locus of care (choice in living arrange-
ments). Two further outcome items, adverse events and
mortality, were removed because they were associated
with clinical interventions and subsequently were judged
inappropriate for a core outcome set measuring individual
outcomes in non-pharmacological health and social care
interventions located in the community.
Sixty-eight outcome items were either merged or
removed, and one outcome item was added (Vision &
hearing) during the workshops. The 54 outcome items
were organised under four domains: Self-Managing
Dementia Symptoms; Quality of Life; Friendly Neigh-
bourhood & Home; Independence Fig. 1.
These 54 outcome items in the ‘long-list’ were formed
into an accessible Delphi survey. The process of devel-
oping the ‘long-list’ into an accessible Delphi survey in-
volved people living with dementia in their capacity as
co-researchers, and will be and is reported on and dis-
cussed elsewhere [24].
Discussion
The methods presented in this paper provide a compre-
hensive account of the identification of 54 outcome
items of importance to key stakeholders, including
people living with dementia, and that are used in exist-
ing trials of non-pharmacological interventions or found
in other key literature.
The status of the perspectives of people living with de-
mentia was a key consideration from the beginning of
this study to address critical limitations that are outlined
earlier. The privileging of people living with dementia’s
perspective is evident in the manner the ‘long-list’ was
formed. For example, outcomes in existing trials were
mapped onto the qualitative framework that was initially
drawn from Bamford and Bruce’s [18] work that pro-
moted perspectives of people living with dementia and
was expanded with outcome items extracted from quali-
tative data collection. Subsequently, many outcomes
found in trials were mapped on to the qualitative frame-
work. Furthermore, a key part of designing an accessible
Delphi survey was utilising the lived experience of
people living with dementia as co-researchers in the
study design [19]. The privileging of the views of people
living with dementia who participated in the study when
forming the ‘long-list’, and their role as co-researchers in
the Delphi design (as reported elsewhere [24]), will en-
sure that the final core outcome set reflects what is im-
portant to those with lived experience.
A further illustration of privileging the views of people
living with dementia is in the qualitative data collection.
Other stakeholder groups were asked to respond in in-
terviews and focus groups through empathic reflection
whereby they considered important outcome items from
the perspective of a person living with dementia, as
opposed to what they thought was important from their
own perspective. There is clearly a distinction between
what a carer or healthcare professional would consider
important, and what they think a person living with
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Table 2 One hundred twenty-one outcomes extracted from qualitative data collection, across literature and their final status
Source No. Initial grouping Outcome Final status
Qualitative data
collection (1–79)
Living with dementia
1 Acceptance of dementia In long-list
2 Access to meaningful activity and stimulation In long-list
3 Access to social contact and company In long-list
4 Being personally clean and comfortable In long-list
5 Choice in living arrangements Removed (not relevant)
6 Feeling financially secure In long-list
7 Feeling safe and secure In long-list
8 Having a sense of social integration In long-list
9 Living in a clean and comfortable environment Merged (4)
10 Maintaining a sense of self In long-list
11 Maintaining a sense of who you are, role/
occupation
In long-list
12 Self-esteem In long-list
13 Having a sense of purpose Merged (11)
14 Religion/spirituality Merged (2)
15 Basic Activities - being able to carry out
basic self-care and basic tasks
In long-list
16 Instrumental/more complex activities In long-list
Maintaining cognition
17 Word finding/language difficulties In long-list
18 Difficulties identifying/counting money/
overspending
In long-list
19 Deterioration (fears it will ‘spread’) In long-list
20 Memory In long-list as 2 items
(short & long term memory)
21 Visuospatial abilities In long-list
22 Confusion/getting lost In long-list
23 Learning new things In long-list
Physical functioning
24 Physical function In long-list
25 Maintaining physical function Merged (27)
26 Falls In long-list
27 Keeping physically active In long-list
28 Balance In long-list
29 Co-morbidity In long-list
30 Mobility In long-list
Maintaining relationships
31 Importance of relationships with family
and friends
In long-list
32 Loss of relationships Merged (31)
33 Reaction of family and friends to diagnosis In long-list
Maximising autonomy
or independence
34 Maintaining independence Became a domain - Independence
35 Being able to make choices/being involved
in choices
Became a domain - Independence
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Table 2 One hundred twenty-one outcomes extracted from qualitative data collection, across literature and their final status
(Continued)
Source No. Initial grouping Outcome Final status
36 Maximising confidence Merged (12)
37 Minimising loneliness or isolation In long-list
Living with others and
the environment
38 Access to appropriate services Removed (Intermediate/service/
process outcome)
39 Information, i.e. having information
about available services/support
Removed (Intermediate/service/
process outcome)
40 Being able to relate to other service users Merged (3)
41 Being treated as an individual Removed (Intermediate/service/
process outcome)
42 Communication In long-list
43 Continuity of hobbies and care Merged (2)
44 Feeling valued and respected by others In long-list
45 Having a safe and secure home Merged (7)
46 Having a safe and secure neighbourhood In long-list
47 Having a say in services Merged (41)
48 Neighbourhood and public awareness
of dementia
Became a domain - Friendly
Neighbourhood & Home
49 Service driven provision Removed (process outcome)
Psychological and
behavioural symptoms
of dementia (BPSD)
Behaviour
50 Frustration In long-list
51 Sleeping In long-list
52 Denial Merged (1)
53 Aggression/abusive behaviour In long-list
54 Agitation In long-list
55 Apathy In long-list
56 Suspicion/paranoia In long-list
57 Changes in personality Removed (present across
BPSD outcomes)
58 Eating In long-list
59 Wandering In long-list
60 Inappropriate speech/disinhibition In long-list
61 Repeated questioning In long-list
62 Hallucinations/delusions In long-list
Mood
63 Anxiety In long-list
64 Embarrassment In long-list
65 Happy In long-list
66 Depression In long-list
The experience of caring
for a person with dementia
67 The effect of caregiving on the carer Removed (not relevant - focus not
on person living with dementia)
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Table 2 One hundred twenty-one outcomes extracted from qualitative data collection, across literature and their final status
(Continued)
Source No. Initial grouping Outcome Final status
68 Carer reaction Removed (not relevant - focus not
on person living with dementia)
Others
69 Quality of life Became a domain - Quality of Life
70 Lived experience Removed (present across many
outcomes)
71 Health and co-morbidity In long-list
72 End of life planning Removed (Intermediate/service/
process outcome)
73 Cultural differences Merged (41)
74 Cost effectiveness of interventions Removed (Intermediate/service/
process outcome)
75 Managing dementia Became a domain - ‘Self-Managing
Dementia Symptoms’
76 Dementia progression Merged (19)
77 Medical events/falls Merged (26)
78 Maintaining everyday activities Merged (2, 15, 16)
79 Support Merged (2, 3, 31, 38)
Additional outcomes
from literature (80–107)
80 Adverse events Removed (not relevant)
81 Aberrant behaviours other than wandering Merged (59)
82 Secretiveness In long-list
83 Hopelessness Merged (66)
84 Subjective memory/cognitive problems Merged (17–23)
85 General cognition Became a domain - ‘Self-Managing
Dementia Symptoms’
86 Alertness In long-list
87 Attachment Merged (31–32)
88 Personal cost to person with dementia/family Removed (process outcome/cost)
89 Mortality Removed (not relevant)
90 Time to significant event Removed (Intermediate/service/
process outcome)
91 Physical environment Merged (part of ‘Friendly
Neighbourhoods & Home’ domain)
92 Medications (Type; Access; management) Merged (15, 16)
93 Medical health markers (cardiac rhythm,
brain activation, brain volume, blood pressure)
Merged (29, 71)
94 Number of contacts with health and social
care professionals
Removed (Intermediate/service/
process outcome)
95 Health Behaviours Removed (Intermediate/service/
process outcome)
96 Weight (also BMI) Merged (93)
97 Sleep In long-list
98 Quality of care process outcomes Removed (Intermediate/service/
process outcome)
99 Health related quality of life Merged (Quality of Life domain
and present across outcomes)
100 Enjoyment Merged (present across ‘Friendly
Neighbourhoods & Home’ domain)
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dementia might deem important. While we recognise
there will be convergence of perspectives to some extent
when a stakeholder reflects in this way, we recognise the
intersubjective nature of multiple perspectives of com-
plex experiences gathered through qualitative data col-
lection methodology [30].
This approach is likely to have produced a different
configuration and description of outcome items when
compared to existing outcome measurement instru-
ments. More specifically, the ‘long-list’ of outcome items
in this paper may present specific individual items that
are part of or regarded as a construct of an existing out-
come or outcome measure, for which single composite
scores tend to be presented. An example is how the indi-
vidual items and constructs in the neuropsychiatric in-
ventory [31] are present in the ‘long-list’ as individual
outcome items. This is the consequence of the methods
undertaken - the interviews and focus groups - in attain-
ing granularity of what outcome items are regarded as
important. We suggest this is a key strength of the work
considering the ‘long-list’ reflects what is valued as im-
portant by people living with dementia and other key
stakeholders.
Given the participants in the qualitative data were
based in the UK the ‘long-list’ has particular relevance
for the UK context as well as being of international
interest. That said, although the trials reviewed were
international, more work is needed to ensure that the
outcome items are as equally applicable for an inter-
national context. It is important to note that the out-
come items in the ‘long-list’ are not salient to any one
type of intervention. The ‘long-list’ may benefit
Table 2 One hundred twenty-one outcomes extracted from qualitative data collection, across literature and their final status
(Continued)
Source No. Initial grouping Outcome Final status
101 Self-efficacy Merged (12)
102 Wellbeing Removed (present across included
outcomes)
103 Use of healthcare Removed (cost related, not
individual outcome)
104 Use of social resources Removed (cost related, not
individual outcome)
105 Use of other organisations Removed (cost related, not
individual outcome)
106 Unmet needs general Removed (not a single outcome)
107 Satisfaction with/acceptability of
intervention
Removed (Intermediate/service/
process outcome)
Additional outcomes
from policy (108–120)
108 Timely diagnosis Removed (Intermediate/service/
process outcome)
109 Stigma or discrimination Merged (44)
110 Sense of humour Merged (114)
111 Research Removed (not an outcome)
112 Reaction of others or wider community Merged (48)
113 Impact of diagnosis Merged (present across all
included outcomes)
114 Having a laugh In long-list
115 Getting out of the house Merged (2, 34, 36)
116 Feeling like a burden In long-list
117 Faith religion or spirituality Merged (2)
118 Enjoyment Merged (100)
119 Empower or protection of rights Removed (Intermediate/service/
process outcome)
120 Dementia friendly environments Merged (48)
Additional outcomes
from key reviews and
qualitative papers
121 Missing something Merged (2, 78)
Added during team
workshops
122 Vision and hearing In long-list
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practitioners, service planners and commissioners as it
serves to direct the focus of health and social care ser-
vices and interventions having been derived through ro-
bust methods and informed by people living with
dementia and carer partners. On this basis, the 54 out-
come items presented in this paper acts as a useful re-
source or an ‘outcome items bank’ for researchers,
service providers and commissioners alike. The ‘long-list’
reported here does not include outcomes relating to care
partners, delivery of care or processes, costs or eco-
nomic related outcomes. Research focusing on care part-
ner related outcomes is warranted as a separate study
and clearly an area of interest for further research.
Conclusions
In COS research that uses a Delphi approach, if a large
quantity of outcome items are found it will often not be
manageable or realistic to include every outcome item
extracted from qualitative research methods and
literature in a Delphi survey. This paper outlines a trans-
parent blueprint around how a ‘long-list’ of outcome
items was formed through a process of extraction from
consultation with key stakeholder groups. In addition,
this paper presents a robust approach to identify dupli-
cation, merge areas and remove unsuitable outcome
items. More broadly, the methods and ‘long-list’ outlined
here are capable of informing wider health and social
care studies where there is a focus on priority setting
and the inclusion of areas of importance to people living
with dementia.
The 54 outcome items in the ‘long-list’ will be distilled
further through a modified Delphi survey with key stake-
holders and a consensus meeting, both including people
living with dementia, where core outcomes will be iden-
tified [19]. In a further phase we will review existing out-
come measurement instruments in order to highlight
how (if at all) measurement instruments measure the
core outcomes identified.
Fig. 1 Fifty-four unique outcomes identified in qualitative research with key stakeholders and existing literature
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